Pancreatic Cancer Research

ResearcherNara Medical UniversityActive in the last 2 years

Hideyuki Nishiofuku

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3691-7278; OpenAlex author ID A5102814879. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 3 papers · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 12

  1. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreat… Co-author DOI 10.1038/s41598-024-61142-y↗
  2. Risk Factors for Late-Onset Gastrointestinal Hemorrhage After Pancreatoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1007/s00268-018-4791-7↗
  3. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.05.461↗
  4. Adjuvant Hepatic Arterial Infusion Chemotherapy After Resection for Pancreatic Cancer Using Coaxial Catheter-Port System Compared with Conventional System. Co-author DOI 10.1007/s00270-016-1292-7↗
  5. Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer. Co-author DOI 10.1007/s00330-015-3999-2↗
  6. Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2015.10.034↗
  7. Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer. Co-author DOI 10.1007/s00423-015-1304-0↗
  8. Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy. Co-author DOI 10.1097/mpa.0000000000000395↗
  9. Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer. Co-author DOI 10.1007/s00534-012-0532-8↗
  10. Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabin… Co-author DOI 10.2214/ajr.11.8008↗
  11. Novel postoperative adjuvant strategy prevents early hepatic recurrence after resection of pancreatic cancer. Co-author DOI 10.1007/s00534-010-0336-7↗
  12. Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer. First author PMID 22110218↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masayuki Sho · 11 shared papers, 2011–2019 · strength 0.56
  2. Kimihiko Kichikawa · 10 shared papers, 2011–2019 · strength 0.52
  3. Takahiro Akahori · 8 shared papers, 2011–2019 · strength 0.45
  4. Toshihiro Tanaka · 9 shared papers, 2011–2019 · strength 0.45
  5. Yoshiyuki Nakajima · 9 shared papers, 2011–2016 · strength 0.38
  6. Minako Nagai · 5 shared papers, 2015–2019 · strength 0.33
  7. Satoshi Nishiwada · 4 shared papers, 2015–2019 · strength 0.24
  8. Chiho Ohbayashi · 3 shared papers, 2015–2019 · strength 0.19
  9. Kota Nakamura · 2 shared papers, 2019 · strength 0.18
  10. Kenji Nakagawa · 2 shared papers, 2019 · strength 0.18
  11. Naoya Ikeda · 2 shared papers, 2019 · strength 0.18
  12. Shoichi Kinoshita · 4 shared papers, 2013–2016 · strength 0.18
  13. Kenjiro Kimura · 1 shared paper, 2024 · strength 0.18
  14. Ryota Tanaka · 1 shared paper, 2024 · strength 0.18
  15. Takeaki Ishizawa · 1 shared paper, 2024 · strength 0.18
  16. Yukio Miki · 1 shared paper, 2024 · strength 0.18
  17. Masanori Ozaki · 1 shared paper, 2024 · strength 0.18
  18. Tadataka Takagi · 1 shared paper, 2019 · strength 0.09
  19. Chihiro Kawaguchi · 2 shared papers, 2013–2015 · strength 0.08
  20. Satoshi Yasuda · 2 shared papers, 2013–2015 · strength 0.08
  21. Ichiro Yamato · 2 shared papers, 2011–2013 · strength 0.05
  22. Aya Hashimoto · 1 shared paper, 2016 · strength 0.05
  23. Kimihiko Kichikaiwa · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.